End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
158.9 EUR | -5.95% | -.--% | -.--% |
Sales 2024 * | 88.37B 81.89B 7,037B | Sales 2025 * | 90.78B 84.12B 7,229B | Capitalization | 364B 337B 28,979B |
---|---|---|---|---|---|
Net income 2024 * | 22.04B 20.42B 1,755B | Net income 2025 * | 23.09B 21.4B 1,839B | EV / Sales 2024 * | 4.04 x |
Net cash position 2024 * | 7B 6.48B 557B | Net cash position 2025 * | 21.07B 19.53B 1,678B | EV / Sales 2025 * | 3.78 x |
P/E ratio 2024 * |
16.8
x | P/E ratio 2025 * |
15.9
x | Employees | 131,900 |
Yield 2024 * |
3.19% | Yield 2025 * |
3.33% | Free-Float | 77.07% |
Latest transcript on Johnson & Johnson
1 day | -5.95% |
Managers | Title | Age | Since |
---|---|---|---|
Joaquin Duato
CEO | Chief Executive Officer | 61 | 31/12/88 |
Joseph Wolk
DFI | Director of Finance/CFO | 57 | 31/12/97 |
James Swanson
CTO | Chief Tech/Sci/R&D Officer | 58 | 04/11/19 |
Members of the board | Title | Age | Since |
---|---|---|---|
Marillyn Hewson
BRD | Director/Board Member | 70 | 24/04/19 |
D. Davis
BRD | Director/Board Member | 72 | 18/06/14 |
Anne Mulcahy
BRD | Director/Board Member | 70 | 21/10/09 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+29.98% | 684B | |
+30.34% | 568B | |
+18.59% | 329B | |
+4.07% | 284B | |
+16.21% | 240B | |
+9.66% | 208B | |
-6.83% | 200B | |
+7.09% | 166B | |
-1.22% | 159B |
- Stock Market
- Equities
- JNJ Stock
- JNJ Stock